| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
17,064 |
14,455 |
$3.02M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,041 |
664 |
$13K |
| 87428 |
|
246 |
223 |
$7K |
| 90686 |
|
490 |
408 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
512 |
474 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,046 |
2,896 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,623 |
10,987 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
390 |
321 |
$789.80 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
734 |
610 |
$478.48 |
| 87400 |
|
124 |
116 |
$389.52 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
176 |
128 |
$329.17 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,069 |
1,956 |
$105.80 |
| 90461 |
|
56 |
14 |
$80.50 |
| 96160 |
|
14 |
14 |
$32.78 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
79 |
72 |
$9.41 |
| 90834 |
Psychotherapy, 45 minutes with patient |
53 |
44 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
152 |
102 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
25 |
12 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
34 |
26 |
$0.00 |